Estudio en fase III, aleatorizado, doble ciego, controlado con placebo, para evaluar el efecto de resmetirom sobre los resultados relacionados con el hígado en pacientes con esteatohepatitis no alcohólica (EHNA) bien compensada (Child-Pugh A) (RESULTADOS DE MAESTRO-NASH).

[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence

Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda

Editorial Material. 10.1016/j.farma.2024.08.009. 2024

[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Andrés JLP, Solsona MDE

Article. 10.1016/j.farma.2023.10.004. 2024

[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024

In vitro personalised model based on induced pluripotent stem cells for studying idiosyncratic hepatotoxicity

Pelecha, M.; (...); Tolosa, L.

Meeting Abstract. 10.1016/j.toxlet.2024.07.291. 2024

A Gadolinium(III) Complex Based on Pyridoxine Molecule with Single-Ion Magnet and Magnetic Resonance Imaging Properties.

Orts-Arroyo, Marta; (...); Martinez-Lillo, Jose

Article. 10.3390/ijms25042112. 2024

Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).

Garcia Morales, Natalia; (...); Cubiella, Joaquin

Article. 10.1016/j.gastrohep.2024.502220. 2024

Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.

Andacoglu, Oya; (...); Selzner, Nazia

Article. 10.3389/ti.2023.11240. 2023

• 
• 
• 2

  

An international, multicenter, survey-based analysis of practice and management of acute liver failure.

Gurakar, Ahmet; (...); Coilly, Audrey

Article. 10.1097/LVT.0000000000000402. 2024

• 
• 
• 2

  

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

• 
• 
• 1

  

Assessment of persistent COVID-19 in liver transplant recipients compared to immunocompetent individuals

Fernandez, A.; (...); Salcedo, M. M.

Meeting Abstract. 2023

CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Correction. 10.1016/j.rec.2023.03.018. 2023

Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.

Garcia-Cortes, Miren; (...); Andrade, Raul J.

Article. 10.1111/liv.15623. 2023

• 
• 
• 14

  

CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)

Aguilera, V.; (...); Berenguer, M.

Meeting Abstract. 2023

CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation

Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel

Meeting Abstract. 2023

Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation

Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2024

Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.

Medina-Caliz, Inmaculada; (...); Alvarez-Alvarez, Ismael

Article. 10.1007/s00204-023-03630-0. 2023

• 
• 
• 5

  

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

• 
• 2

  

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.

De Vincentis, Antonio; (...); Carbone, Marco

Article. 10.1016/j.cgh.2024.05.008. 2024

• 
• 3

  

Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1111/liv.15766. 2024

• 
• 
• 5

  

Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?

Trapero-Marugan, M.; (...); Cuervas-Mons, V.

Meeting Abstract. 2023

Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2023

EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023

Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024

External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients

Sahuco, Ivan; (...); Berenguer, Marina

Meeting Abstract. 2023

External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1002/ueg2.12571. 2024

FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2024

FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2024

FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.

Martinez-Arenas, Laura; (...); Berenguer, Marina

Article. 10.1111/liv.16085. 2024

GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.

Rodríguez-Perálvarez ML; (...); Gastaca M

Article. 10.1016/j.eclinm.2024.102737. 2024

• 
• 
• 9

  

Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, Isabel; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023

Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

• 
• 
• 6

  

Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)

Gratacos-Gines, Jordi; (...); Pose, Elisa

Meeting Abstract. 2024

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

• 
• 
• 3

  

Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2023

Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study

Diaz-Gonzalez, Alvaro; (...); Crespo, Javier

Meeting Abstract. 2024

Increased cardiovascular risk post-LT in HIV-infected patients? An ELTR based multicenter study

Vinaixa, C.; (...); Aguilera, M. V.

Meeting Abstract. 2024

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

• 
• 
• 5

  

Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

• 
• 2

  

Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.

Magaz, Marta; (...); Garcia-Pagan, Juan Carlos

Article. 10.1097/TP.0000000000004444. 2022

• 
• 22

  

Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023

Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.

Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria

Article. 10.1016/j.trre.2024.100875. 2024

• 
• 
• 6

  

MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2023

Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors

Martin-Mateos, R.; (...); Albillos, A.

Meeting Abstract. 2024

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

• 
• 
• 1

  

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

• 
• 
• 1

  

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

• 
• 
• 4

  

Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantation.

Cox B; (...); Selzner N

Article. 10.1097/LVT.0000000000000274. 2023

• 
• 2

  

Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.

Marti-Aguado D; (...); Marti-Bonmati L

Article. 10.3389/fendo.2023.1213441. 2023

• 
• 
• 3

  

Porto sinusoidal vascular liver disorder: natural history and long-term outcome

Magaz, Marta; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.

Magaz, Marta; (...); Garcia-Pagan, Juan Carlos

Article. 10.1016/j.jhep.2024.07.035. 2024

• 
• 13

  

PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)

De Vincentis, Antonio; (...); Carbone, Marco

Meeting Abstract. 2023

Predictive models of treatment benefit in patients with autoimmune hepatitis and decompensated cirrhosis at diagnosis

Arvaniti, Pinelopi; (...); Carlota Londono, Maria

Meeting Abstract. 2023

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Fernandez, Ainhoa; (...); Salcedo, Magdalena

Meeting Abstract. 2023

Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Fernandez-Yunquera, A.; (...); Salcedo, M. M.

Meeting Abstract. 2023

Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.

Minguez, Alejandro; (...); Berenguer, Marina

Article. 10.1007/s10620-024-08368-y. 2024

Proceedings of the 27th Annual Congress of the International Liver Transplantation Society.

Campos-Varela, Isabel; (...); De Martin, Eleonora

Article. 10.1097/TP.0000000000004637. 2023

Proceedings of the 28th annual congress of the international liver transplantation society.

Shaji Mathew, Johns; (...); Chadha, Ryan

Article. 10.1097/LVT.0000000000000330. 2024

Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict

Silva, Silvia Gomes; (...); Cardoso, Joana

Meeting Abstract. 2024

Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

Diaz-Gonzalez, Alvaro; (...); Crespo, Javier

Meeting Abstract. 2024

Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Ruiz-Cobo, Juan Carlos; (...); Lens, Sabela

Meeting Abstract. 2023

Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence

Gratacos, Jordi; (...); Pose, Elisa

Meeting Abstract. 2023

Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments

Giuliani, Tommaso; (...); Lopez-Andujar, Rafael

Article. 10.1159/000539460. 2024

Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.

Gratacos-Gines, Jordi; (...); Pose, Elisa

Article. 10.1097/HEP.0000000000000825. 2024

• 
• 1

  

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial

Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023

The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024

The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)

Gratacos-Gines, Jordi; (...); Pose, Elisa

Meeting Abstract. 2024

The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

Rodriguez-Tajes, Sergio; (...); Forns, Xavier

Article. 10.1111/liv.15777. 2024

• 
• 
• 2

  

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024

• 
• 1

  

Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey

Vinaixa, C.; (...); Terrault, N.

Meeting Abstract. 2024

Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.

Vinaixa, Carmen; (...); Berenguer, Marina

Article. 10.1097/LVT.0000000000000432. 2024

• 
• 
• 1

  

Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain

Rodriguez-Peralvarez, Manuel; (...); Gastaca, Mikel

Meeting Abstract. 2024

VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023

Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications

Garcia Garcia, S.; (...); Aguilera, V.

Meeting Abstract. 2023

Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.

Di Maira, Tommaso; (...); Berenguer, Marina

Article. 10.3389/frtra.2023.1332616. 2023